Abiomed (ABMD:NASDAQ) is a leading provider of medical devices that provide circulatory support. The stock has been on a tear lately, eclipsing $430/share. The 7/20/18 260 calls are fetching a 6.10 bid for a nice 1.4% premium.

 

DISCLOSURE: This post is for informational purposes only and should not be relied upon as investment advice. All investing involves risk and each person’s situation is unique. Perform your own due diligence or consult with a qualified advisor before investing.

Options are specialized instruments and are not suitable for everyone. Prior to buying or selling an option, investors must read a copy of the Characteristics & Risks of Standardized Options, also known as the options disclosure document (ODD), located here